Nano Holdings, Inc. (TSE: 4571)
Health Care · Biotechnology · JP
¥108.00
+2.86% today · -28.0% 1Y
Nano Holdings, Inc. (TSE: 4571) operates in the Biotechnology industry within the Health Care sector. The company is valued at $60.72M and employs 23 people.
Over the last twelve months the share price has lost 28.0%, trading between 93.00 and 254.00.
Tweenvest scores Nano Holdings, Inc. across four factors: quality 32/100, value 41/100. Its strongest factor is value.
4571 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $60.72M
- Revenue (TTM)
- $1.24M
- P/E
- —
- EPS
- -13.43
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- ¥254.00
- 52-week low
- ¥93.00
- Avg volume (3M)
- —
- Shares outstanding
- 89.39M
- Employees
- 23
- Next earnings
- —
About Nano Holdings, Inc.
NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing oncological conditions and a range of other severe illnesses. The enterprise also undertakes the full spectrum of activities for anti-cancer medications, from initial scientific investigation to market commercialization, all underpinned by its distinctive micellar nanoparticle approach. Established on June 14, 1996, by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi, the firm maintains its principal operations in Tokyo, Japan.
- ISIN
- JP3651120002
- Founded
- 1996
- Listed since
- Mar 5, 2008
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.07 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.98 | +0.26% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.96 | +0.15% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $549.00 | +0.26% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $834.94 | +0.78% |
| argenx SEENXTBR: ARGX | $63.06B | €872.80 | +1.00% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.62 | +1.97% |
Figures last refreshed Aug 18, 2026.